Miquel Angel Pujana

This user account status is Approved

This user has not added any information to their profile yet.

Miquel Angel
Procure, Catalan Institute of Oncology, IDIBELL
Cancer biology, therapy, resistance, network models, systems biology, genetics, BRCA1/2, triple-negative, endocrine resistance, genetics, risk
Genetics, data integration and modeling, functional genomics, synergistic drug combinations, predictions, resistance, risk
Transgenic Rosa-HMMR, loss of function Brca1/p53, cell lines resistant for endocrine therapy and mTOR inhibition, PDXs of TNBC and endocrine resistance